CAJ | 학술논문

钾盐型磷酸镁水泥(MKPC)于2009年作为骨修复材料获得美国FDA的认证,目前已在美国临床使用.这种生物材料具有强大的黏合性,能把骨、韧带和肌腱黏附到骨;同时还具有良好的生物相容性、适度的生物降解性和成骨活性,是目前惟一既具有黏合性又具有成骨活性的骨修复材料.此新型材料进入临床必将给骨外科及其相关学科的治疗带来前所未有的改变.概述了MKPC的发展、组成与制备特点、反应机制、应用研究以及具有的优势.
갑염형린산미수니(MKPC)우2009년작위골수복재료획득미국FDA적인증,목전이재미국림상사용.저충생물재료구유강대적점합성,능파골、인대화기건점부도골;동시환구유량호적생물상용성、괄도적생물강해성화성골활성,시목전유일기구유점합성우구유성골활성적골수복재료.차신형재료진입림상필장급골외과급기상관학과적치료대래전소미유적개변.개술료MKPC적발전、조성여제비특점、반응궤제、응용연구이급구유적우세.
A kind of magnesium potassium phosphate cement developed for bone repair was cleared by FDA in 2009 and has been presently in clinical use in America.The biomaterial has the powerful adhesive capability to bind bone,ligament,and tendon to bone,as well as possessing good biocompatiblity,appropriate biodegradability and osteogenicity; to data,it is the only material which possesses the combination of adhesivity and osteogenicity among bone repair biomaterials.The clinical application of the innovative biomaterial will unprecedentedly alter the treatment in orthopedic surgery and related disciplines.To provide a comprehensive appreciation of the innovative biomaterial,this article summaries its development,characteristics of composition and preparation,formation mechanism,application study and superiority.